Camallergy, also known as Cambridge Allergy Ltd, stands as a pioneering biopharmaceutical company deeply dedicated to transforming the treatment landscape for individuals worldwide grappling with food allergies.

The project’s core objective involved the deconstruction and construction of a pharmaceutical production unit specifically designed for the application and testing of pioneering medications derived from advanced research, aimed at aiding patients in overcoming food allergies.